JOINT FILING AGREEMENT
Exhibit
2
In
accordance with Rule 13d-1(k)(1) under the Securities Exchange Act
of 1934, as
amended, each of the undersigned Reporting Persons hereby agrees to
the joint
filing, along with all other such Reporting Persons, on behalf of each
of them
of a statement on Schedule 13G (including amendments thereto) with
respect to
the Common Stock, $0.01 par value, of Endo Pharmaceuticals Holdings
Inc., and
that this Agreement be included as an Exhibit to such joint filing.
This
Agreement may be executed in any number of counterparts, all of which
taken
together shall constitute one and the same instrument.
IN
WITNESS WHEREOF, each of the undersigned hereby executes this Agreement
as of
this 2nd
day of
May, 2008.
|
|||
|
By:
|
X.
X. Xxxx & Co., L.P., as
managing
member
|
|
|
|
|
|
By: | /s/ Xxxxxxxx Xxxxx | ||
|
|
|
Xxxxxxxx
Xxxxx
Chief
Compliance Officer
|
X. X. Xxxx & Co., L.P. | ||
|
|
|
By: | /s/ Xxxxxxxx Xxxxx | |
Xxxxxxxx
Xxxxx
Chief
Compliance Officer
|
Xxxxx X. Xxxx | ||
|
|
|
By: | /s/ Xxxxxxxx Xxxxx | |
Xxxxxxxx
Xxxxx
Attorney-in-Fact
for Xxxxx X.
Xxxx
|